Agennix - World Leader in Development of Recombinant Human Lactoferrin (RhLF)

Executive Management

		Rick G. Barsky Chief Executive Officer Email

		Atul Varadhachary, M.D., Ph.D. President and Chief Operating Officer Email

		Rajesh Malik, M.D. Chief Medical Officer Email

		John Schaumberg, Ph.D. Senior Vice-President, Clinical Operations Email

		Karel Petrak, Ph.D. Vice President of Research & Development Email

		Yenyun Wang, M.D. Executive Director, Clinical Development Email

Founding Chairman

		Gordon A. Cain Founding Chairman, Agennix

Board of Directors

Frank Young, M.D., Ph.D.
Chairman of the Board, Agennix

Rick G. Barsky
Chief Executive Officer, Agennix

Atul Varadhachary, M.D., Ph.D.
President and Chief Operating Officer, Agennix

Rob van Leen, Ph.D.
Chief Innovation Officer, DSM

James Weaver
President, Gordon and Mary Cain Foundation